Concepedia

Thomas Weller

TW

Statistics

Publications

39

Citations

2.7K

H-Index

24

Active since

1979

Affiliations

Actelion (Switzerland)(Current)

ETH Zurich

University of Freiburg

Roche (Switzerland)

University of Basel

Thomas Weller is an author at Actelion (Switzerland) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1979–2016

39

Publications

39

Promotion of sleep by targeting the orexin system in rats, dogs and humans

Catherine Brisbare‐Roch, Jasper Dingemanse, Ralf Koberstein et al. · Nature Medicine · 2007 · 567 citations

, , +12

Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

Marc Iglarz, Christoph A. Binkert, Keith Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 325 citations

, , +10

Low molecular weight, non-peptide fibrinogen receptor antagonists

Leo Alig, Albrecht Edenhofer, Paul Hadváry et al. · Journal of Medicinal Chemistry · 1992 · 192 citations

, , +9

2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P<sub>1</sub>Receptor Agonists

Martin H. Bolli, Stefan Abele, Christoph A. Binkert et al. · Journal of Medicinal Chemistry · 2010 · 178 citations · Full text

, , +17

The Discovery of <i>N</i>-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-<i>N</i>′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist

Martin H. Bolli, Christoph Boss, Christoph A. Binkert et al. · Journal of Medicinal Chemistry · 2012 · 148 citations · Full text

, , +17

1–5 of 39